Inhoud
Menu
Hoofdmenu
Home
Actueel
Onderwerpen
Subsidies & Financiering
Over ons
Service menu right
english.rvo.nl
Direct regelen
Home
Development of a small-molecule based CD47 Immune Checkpoint inhibitor for the treatment of cancer patients
Terug naar details